[1]
Bobtina , N. et al. 2026. Diagnostic and Cost Benefits of Tissue Microarray Technology for Multiplex Biomarker Testing in Molecular Oncology: A Libyan Perspective. Libyan Journal of Medical Research. 20, 1 (Jan. 2026), 156–165. DOI:https://doi.org/10.54361/LJMR.20.1.24.